Suchergebnisse - "Chino, Yukihiro"

PubPharm (23)

1

Population Pharmacokinetics of Ozoralizumab in Patients with Rheumatoid Arthritis

enthalten in: Journal of clinical pharmacology | 2024

von Takeuchi, T. | Chino, Y. | Mano, Y. | +4

2

Population Pharmacokinetics of Ozoralizumab in Patients with Rheumatoid Arthritis

enthalten in: The Journal of Clinical Pharmacology | 2024

von Takeuchi, T. | Chino, Y. | Mano, Y. | +4

3

Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα NANOBODY® compound, in patients with rheumatoid arthritis : 52-week results from the OHZORA and NATSUZORA trials

enthalten in: Arthritis research & therapy | 2023

von Takeuchi, T. | Chino, Y. | Kawanishi, M. | +6

4

Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα $ NANOBODY^{®} $ compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials

enthalten in: Arthritis Research & Therapy | 2023

von Takeuchi, T. | Chino, Y. | Kawanishi, M. | +6

5

Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα $ NANOBODY^{®} $ compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials

enthalten in: Arthritis Research & Therapy | 2023

von Takeuchi, T. | Chino, Y. | Kawanishi, M. | +6

6

Factors Influencing Change in Serum Uric Acid After Administration of the Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin in Patients With Type 2 Diabetes Mellitus

enthalten in: Journal of clinical pharmacology | 2022

von Chino, Y. | Kuwabara, M. | Hisatome, I.

7

Factors Influencing Change in Serum Uric Acid After Administration of the Sodium‐Glucose Cotransporter 2 Inhibitor Luseogliflozin in Patients With Type 2 Diabetes Mellitus

enthalten in: The Journal of Clinical Pharmacology | 2022

von Chino, Y. | Kuwabara, M. | Hisatome, I.

8

In vitro evaluation of potential drug interactions mediated by cytochrome P450 and transporters for luseogliflozin, an SGLT2 inhibitor

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2017

von Chino, Y. | Hasegawa, M. | Fukasawa, Y. | +6

9

Metabolite profiling and enzyme reaction phenotyping of luseogliflozin, a sodium-glucose cotransporter 2 inhibitor, in humans

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2017

von Miyata, A. | Hasegawa, M. | Hachiuma, K. | +9

10

Metabolite profiling and enzyme reaction phenotyping of luseogliflozin, a sodium–glucose cotransporter 2 inhibitor, in humans

enthalten in: Xenobiotica | 2017

von Miyata, A. | Hasegawa, M. | Hachiuma, K. | +9